CNSP Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
CNS Pharmaceuticals Inc (CNSP) is not a strong buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The stock shows bearish technical indicators, poor financial performance, and lacks positive catalysts or significant trading sentiment. It is better to hold off on investing in this stock until there are clearer signs of improvement in financials or market sentiment.
The stock is currently in a bearish trend with SMA_200 > SMA_20 > SMA_5. RSI indicates the stock is oversold at 17.222, but the MACD histogram is positively contracting at 0.00236. Key support is at 2.183, and resistance is at 3.377. The stock closed at 2.21, below the pivot level of 2.78.
NULL identified. No recent news or significant trading trends from hedge funds, insiders, or Congress. The stock is oversold, which could attract some short-term interest, but there are no strong long-term growth signals.
The company's financials are weak, with Q3 2025 showing a 42.59% YoY drop in net income and a 96.20% YoY drop in EPS. The stock also lacks recent positive news or trading sentiment. Analysts have not provided any recent ratings or price targets for CNSP.
In Q3 2025, revenue remained stagnant at 0, net income dropped by -42.59% YoY to -3,218,481, and EPS fell by -96.20% YoY to -5.76. Gross margin remained at 0, showing no improvement.
No recent analyst ratings or price targets for CNSP. The provided analyst ratings and price targets are for Centerspace, a different company, and are not relevant to CNSP.
